ArticleAdvances in therapy2021

A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study.

Shizuka Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.